GSK Overly Squeamish About Crest Sensi-Stop Strips Claims – NAD
This article was originally published in The Rose Sheet
Executive Summary
P&G emerges largely unscathed from a National Advertising Division dispute regarding claims for Crest Sensi-Stop Strips, which challenger GlaxoSmithKline Consumer Healthcare argued were unsupported, including the product name. NAD determined the firm’s evidence adequate to support claims of immediate relief and protection for up to one month, among other statements made in ads and on product packaging.